Početna › Limfom plaštanih stanica › Washington › Seattle
Kliničke studije za Limfom plaštanih stanica u gradu Seattle, WA
12 studija za Limfom plaštanih stanica traži sudionike na lokacijama u gradu Seattle i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
U tijeku regrutacijaFaza 1/2
- Research Site, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
U tijeku regrutacijaFaza 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
U tijeku regrutacijaFaza 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
U tijeku regrutacijaFaza 1
- Swedish Cancer Institute (SCI), Seattle
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1
- Fred Hutchinson Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
U tijeku regrutacijaFaza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
U tijeku regrutacijaFaza 1
- Fred Hutchinson Cancer Center, Seattle
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
U tijeku regrutacijaFaza 1
- Providence Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
U tijeku regrutacijaFaza 1
- Swedish Cancer Institute, Seattle
Studije za Limfom plaštanih stanica u drugim gradovima
- Baldwin Park, CA15 studija
- Houston, TX15 studija
- Durham, NC13 studija
- New York City, NY12 studija
- Milwaukee, WI12 studija
- Boston, MA11 studija
- Columbus, OH11 studija
- Nashville, TN11 studija
- Chicago, IL10 studija
- Portland, OR9 studija
- Rochester, MN9 studija
- St. Louis, MO8 studija
Ostale studije u gradu Seattle
- Nemikrocelularni karcinom pluća53 studija
- Rak (sve vrste)49 studija
- Rak prostate42 studija
- Akutna mijeloična leukemija40 studija
- Rak dojke39 studija
- Metastatski karcinom39 studija
- Kolorektalni rak34 studija
- Rak pluća33 studija
- Rak jajnika30 studija
- Multipli mijelom22 studija
- Mijelodisplastični sindromi21 studija
- Akutna limfoblastna leukemija21 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.